Giordano A - Search Results

1

Is there a standard chemotherapeutic regimen for hormone-refractory prostate cancer? Present and future approaches in the management of the disease.

Di Lorenzo G, Autorino R, De Laurentiis M, Bianco R, Lauria R, Giordano A, De Sio M, D'Armiento M, Bianco AR, De Placido S. Di Lorenzo G, et al. Among authors: giordano a. Tumori. 2003 Jul-Aug;89(4):349-60. doi: 10.1177/030089160308900402. Tumori. 2003. PMID: 14606635 Review.

2

FOLFOX-4 in pre-treated patients with advanced transitional cell carcinoma of the bladder.

Di Lorenzo G, Autorino R, Giordano A, Giuliano M, D'Armiento M, Bianco AR, De Placido S. Di Lorenzo G, et al. Among authors: giordano a. Jpn J Clin Oncol. 2004 Dec;34(12):747-50. doi: 10.1093/jjco/hyh132. Jpn J Clin Oncol. 2004. PMID: 15640506

3

Orbital metastasis as a first indication of prostate cancer: a case report.

Autorino R, Zito A, Di Giacomo F, Cosentino L, Quarto G, Di Lorenzo G, Mordente S, Pane U, Giordano A, D'Armiento M. Autorino R, et al. Among authors: giordano a. Arch Ital Urol Androl. 2005 Jun;77(2):109-10. Arch Ital Urol Androl. 2005. PMID: 16146273

4

Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer.

Di Lorenzo G, Autorino R, Giuliano M, Morelli E, Giordano A, Napodano G, Russo A, Benincasa G, D'Armiento M, Altieri V, De Placido S. Di Lorenzo G, et al. Among authors: giordano a. Urology. 2007 Feb;69(2):347-51. doi: 10.1016/j.urology.2006.10.007. Urology. 2007. PMID: 17320676 Clinical Trial.

5

Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials.

De Laurentiis M, Cancello G, D'Agostino D, Giuliano M, Giordano A, Montagna E, Lauria R, Forestieri V, Esposito A, Silvestro L, Pennacchio R, Criscitiello C, Montanino A, Limite G, Bianco AR, De Placido S. De Laurentiis M, et al. Among authors: giordano a. J Clin Oncol. 2008 Jan 1;26(1):44-53. doi: 10.1200/JCO.2007.11.3787. J Clin Oncol. 2008. PMID: 18165639

6

Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study.

Di Lorenzo G, Figg WD, Fossa SD, Mirone V, Autorino R, Longo N, Imbimbo C, Perdonà S, Giordano A, Giuliano M, Labianca R, De Placido S. Di Lorenzo G, et al. Among authors: giordano a. Eur Urol. 2008 Nov;54(5):1089-94. doi: 10.1016/j.eururo.2008.01.082. Epub 2008 Feb 5. Eur Urol. 2008. PMID: 18276061 Clinical Trial.

7

Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer.

Cancello G, Montagna E, D'Agostino D, Giuliano M, Giordano A, Di Lorenzo G, Plaitano M, De Placido S, De Laurentiis M. Cancello G, et al. Among authors: giordano a. Breast Cancer Res. 2008;10(4):R60. doi: 10.1186/bcr2119. Epub 2008 Jul 16. Breast Cancer Res. 2008. PMID: 18631394 Free PMC article.

8

Molecular mechanism and clinical implications of endocrine therapy resistance in breast cancer.

Arpino G, De Angelis C, Giuliano M, Giordano A, Falato C, De Laurentiis M, De Placido S. Arpino G, et al. Among authors: giordano a. Oncology. 2009;77 Suppl 1:23-37. doi: 10.1159/000258493. Epub 2010 Feb 2. Oncology. 2009. PMID: 20130429 Review.

9

Effects of the ErbB1/ErbB2 kinase inhibitor GW2974 on androgen-independent prostate cancer PC-3 cell line growth and NSE, chromogranin A and osteopontin content.

Terracciano D, Mazzarella C, Di Carlo A, Mariano A, Ferro M, Di Lorenzo G, Giordano A, Altieri V, De Placido S, Macchia V. Terracciano D, et al. Among authors: giordano a. Oncol Rep. 2010 Jul;24(1):213-7. doi: 10.3892/or_00000848. Oncol Rep. 2010. PMID: 20514464

10

Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.

Giuliano M, Schettini F, Rognoni C, Milani M, Jerusalem G, Bachelot T, De Laurentiis M, Thomas G, De Placido P, Arpino G, De Placido S, Cristofanilli M, Giordano A, Puglisi F, Pistilli B, Prat A, Del Mastro L, Venturini S, Generali D. Giuliano M, et al. Among authors: giordano a. Lancet Oncol. 2019 Oct;20(10):1360-1369. doi: 10.1016/S1470-2045(19)30420-6. Epub 2019 Sep 4. Lancet Oncol. 2019. PMID: 31494037

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,763 results

Search Page